Concepedia

Michel‐Olivier Gratton

MG

Statistics

Publications

4

Citations

461

H-Index

4

Active since

2001

Affiliations

McGill University(Current)

Xenon Pharmaceuticals (Canada)

Montreal Neurological Institute and Hospital

Michel‐Olivier Gratton is an author at McGill University specializing in natural sciences, medicine, and transcriptional regulation.

ORCID

Top concepts

Publications per year

2001–2009

4

Publications

4

The Small Molecule GMX1778 Is a Potent Inhibitor of NAD <sup>+</sup> Biosynthesis: Strategy for Enhanced Therapy in Nicotinic Acid Phosphoribosyltransferase 1-Deficient Tumors

Mark H. Watson, Anne Roulston, Laurent Bélec et al. · Molecular and Cellular Biology · 2009 · 218 citations · Full text

Hes6 Promotes Cortical Neurogenesis and Inhibits Hes1 Transcription Repression Activity by Multiple Mechanisms

Michel‐Olivier Gratton, Elena Torban, Stéphanie Bélanger Jasmin et al. · Molecular and Cellular Biology · 2003 · 121 citations · Full text

, , +15

HES6 acts as a transcriptional repressor in myoblasts and can induce the myogenic differentiation program

Xiangming Gao, Tanya Chandra, Michel‐Olivier Gratton et al. · The Journal of Cell Biology · 2001 · 62 citations · Full text

Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777

Pierre Beauparlant, Dominique Bédard, Cynthia Bernier et al. · Anti-Cancer Drugs · 2009 · 60 citations

, , +18

1–4 of 4